Keyword: Bayer

News

Biogen Wins EU Backing for Big New MS Drug Hope

22.03.2013 - European regulators have recommended approval of two new multiple sclerosis pills from Biogen and Sanofi, both of which are expected to become major sellers. Friday's decision by...

News

In Europe’s Chemical Boardrooms, Caution Reigns

21.03.2013 - Weal and Woe - Despite pressure from the currency crisis, volatile markets and weak demand in some countries, the performance of the European chemical industry in 2012 was better...

News

EU Could Impose Pesticide Ban to Protect Bees

15.03.2013 - EU governments failed to agree a ban on three widely used pesticides linked to the decline of honeybees on Friday, but the European Commission could force one through by the summer...

News

India Rules Against Bayer in Cancer Drug Patent Case

04.03.2013 - An Indian patent appeals board dismissed on Monday Bayer's petition against a government decision to allow a domestic company to sell cheap copycat versions of cancer drug Nexavar...

News

Bayer 2013 Outlook Slightly Below Market View

28.02.2013 - Germany's largest drugmaker Bayer gave a 2013 underlying earnings forecast that was slightly below analyst expectations amid competition for one of its most promising new drugs...

News

DuPont Sees Growth as Farmers Seek Drought-hardy Corn

23.02.2013 - U.S. farmers are clamoring for more drought-hardy corn seeds as the spring planting season nears and soils remain parched across large swaths of key growing areas, the head of one...

News

Science Driven By the Market

22.02.2013 - When new company chieftains say they want to be a catalyst for change, many listeners brush it off as a tired cliché. Patrick Thomas is proof that it needn't be. Stepping into his...

News

Heavy Flu Season Helps Reckitt Beat Profit Forecasts

13.02.2013 - An unusually severe cold and flu season in the United States helped drive full-year profits higher at Britain's Reckitt Benckiser, maker of Strepsils throat lozenges and Mucinex...